title: Poly(2-aminoethyl methacrylate) with well-defined chain length for DNA vaccine delivery to dendritic cells.
abstract: Poly(2-aminoethyl methacrylate) (PAEM) homopolymers with defined chain length and narrow molecular weight distribution were synthesized using atom transfer radical polymerization (ATRP), and a comprehensive study was conducted to evaluate the colloidal properties of PAEM/plasmid DNA polyplexes, the uptake and subcellular trafficking of polyplexes in antigen-presenting dendritic cells (DCs), and the biological performance of PAEM as a potential DNA vaccine carrier. PAEM of different chain length (45, 75, and 150 repeating units) showed varying strength in condensing plasmid DNA into narrowly dispersed nanoparticles with very low cytotoxicity. Longer polymer chain length resulted in higher levels of overall cellular uptake and nuclear uptake of plasmid DNA, but shorter polymer chains favored intracellular and intranuclear release of free plasmid from the polyplexes. Despite its simple chemical structure, PAEM transfected DCs very efficiently in vitro in media with or without serum and led to phenotypic maturation of DCs. When a model antigen-encoding ovalbumin plasmid was used, transfected DCs stimulated the activation of naïve CD8(+) T cells to produce high levels of interferon-γ. The efficiency of transfection, DC maturation, and CD8(+) T cell activation showed varying degrees of polymer chain-length dependence. These structurally defined cationic polymers may have much potential as efficient DNA vaccine carriers and immunostimulatory adjuvants. They may also serve as a model material system for elucidating structural and intracellular mechanisms of polymer-mediated DNA vaccine delivery.
authors.affiliation: Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.
authors.forename: Weihang
authors.initials: W
authors.lastname: Ji
authors.forename: David
authors.initials: D
authors.lastname: Panus
authors.forename: R Noelle
authors.initials: RN
authors.lastname: Palumbo
authors.forename: Rupei
authors.initials: R
authors.lastname: Tang
authors.forename: Chun
authors.initials: C
authors.lastname: Wang
mesh_terms: D001692:Biological Transport / Q000502:physiology; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism; D004247:DNA / Q000737:chemistry / Q000235:genetics; D003713:Dendritic Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D016503:Drug Delivery Systems / Q000379:methods*; D007371:Interferon-gamma / Q000096:biosynthesis; D008213:Lymphocyte Activation; D008689:Methacrylates / Q000138:chemical synthesis* / Q000737:chemistry; D053758:Nanoparticles; D010957:Plasmids; D011108:Polymers / Q000138:chemical synthesis / Q000737:chemistry; D014162:Transfection / Q000379:methods; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000494:pharmacology
chemical_list: D008689:Methacrylates; D011108:Polymers; D019444:Vaccines, DNA; C072703:2-aminoethylmethacrylate; D007371:Interferon-gamma; D004247:DNA
references.citation: Adv Mater. 2009 Feb 23;21(8):847-867
references.pmid: 28413262
references.citation: Biomacromolecules. 2009 May 11;10(5):1244-52
references.pmid: 19331402
references.citation: Biomacromolecules. 2010 Dec 13;11(12):3432-9
references.pmid: 21067136
references.citation: Nat Rev Drug Discov. 2005 Jul;4(7):581-93
references.pmid: 16052241
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Mol Ther. 2004 Mar;9(3):443-51
references.pmid: 15006612
references.citation: Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5177-81
references.pmid: 10220439
references.citation: Immunol Rev. 2005 Oct;207:166-83
references.pmid: 16181335
references.citation: J Biomater Sci Polym Ed. 2011;22(9):1215-36
references.pmid: 20615356
references.citation: Mol Ther. 2005 Jul;12(1):164-70
references.pmid: 15963932
references.citation: Gene Ther. 1999 Apr;6(4):643-50
references.pmid: 10476224
references.citation: J Invest Dermatol. 2005 Jan;124(1):160-9
references.pmid: 15654970
references.citation: Cell. 2001 Aug 10;106(3):255-8
references.pmid: 11509172
references.citation: J Control Release. 2001 Nov 9;77(1-2):131-8
references.pmid: 11689266
references.citation: J Control Release. 2010 Mar 3;142(2):229-37
references.pmid: 19874858
references.citation: Biotechnol Appl Biochem. 2003 Jun;37(Pt 3):267-71
references.pmid: 12597775
references.citation: Pharm Res. 2004 Jan;21(1):160-9
references.pmid: 14984271
references.citation: Nat Med. 1999 Apr;5(4):387-91
references.pmid: 10202926
references.citation: Biochim Biophys Acta. 2000 Dec 15;1517(1):1-18
references.pmid: 11118611
references.citation: J Biomed Mater Res. 1999 Jun 5;45(3):268-75
references.pmid: 10397985
references.citation: Biomacromolecules. 2004 Mar-Apr;5(2):379-88
references.pmid: 15002997
references.citation: Biomaterials. 2007 Jun;28(18):2885-98
references.pmid: 17367850
references.citation: J Am Chem Soc. 2005 Mar 30;127(12):4128-9
references.pmid: 15783168
references.citation: Int Rev Immunol. 2006 May-Aug;25(3-4):99-123
references.pmid: 16818367
references.citation: Mol Ther. 2009 Mar;17(3):480-90
references.pmid: 19142180
references.citation: Immunol Lett. 2003 Dec 15;90(2-3):67-70
references.pmid: 14687705
references.citation: Chem Rev. 2001 Sep;101(9):2921-90
references.pmid: 11749397
references.citation: J Gene Med. 2005 Oct;7(10):1287-98
references.pmid: 15906395
references.citation: J Control Release. 2012 Jan 10;157(1):86-93
references.pmid: 21907252
references.citation: Chem Rev. 2009 Feb;109(2):259-302
references.pmid: 19053809
references.citation: Eur J Immunol. 2008 May;38(5):1404-13
references.pmid: 18389478
references.citation: Pharm Res. 2008 Sep;25(9):2083-93
references.pmid: 18452054
references.citation: Mol Ther. 2003 Feb;7(2):254-61
references.pmid: 12597914
references.citation: Biomacromolecules. 2004 Jan-Feb;5(1):32-9
references.pmid: 14715005